Katherine Stueland

Dendreon Corp. discovers, develops and commercializes novel products for the treatment of cancer. The company applies its expertise in antigen identification, engineering and cell processing to produce active cellular immunotherapy ACI product candidates designed to stimulate an immune response in a variety of tumor types. It is an exploring the application of additional ACI product candidates and small molecules for the potential treatment of a variety of cancers. Dendreon was founded by Christopher S. Henney, Edgar G. Engleman and Samuel Strober in 1992 and is headquartered in Seattle, WA.

GeneDx, Inc. provides genetic testing for rare hereditary disorders. It offers diagnostic tests for gene, disease, mitochondria, inherited metabolic, and eye disorders; gene deletion/duplication analysis services; and molecular cytogenetic, prenatal genetic, mutation-specific, autism/autism spectrum disorder, cardiology genetic, and mutation confirmation tests. The company was founded by John Compton and Sherri Bale in 2000 and is headquartered in Gaithersburg, MD.

Rivkin Center for Ovarian Cancer is a non-profit organization that funds ovarian cancer research, screening, and educational programs for women. The company was founded by Saul E. Rivkin in 1996 and is headquartered in Seattle, WA.

Vivo Communications, LLC provides telecommunication services. The private company is based in Seattle, WA.

Mount Sinai Genomics, Inc. operates online predictive health analysis platform for diagnosis, treatment and prevention of diseases. It offers Centrellis which analyzes and interprets extensive information about known inherited diseases, including related mutations, frequency across populations, and the penetrance and expressivity of genetic changes. The company was founded by Eric Schadt and is headquartered in Stamford, CT.

Part of GeneDx Holdings Corp., GeneDx LLC is a private company that provides genomic testing services. The company is based in Stamford, CT. The company was founded in 2000. Katherine A. Stueland has been the CEO of the company since 2021.